Drug profile · INN
unoprostone isopropyl
RESCULA
unoprostone isopropyl (RESCULA) is a unknown. Route of administration: ophthalmic. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — unoprostone isopropyl
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
unoprostone isopropyl (RESCULA) is a unknown. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
INN unoprostone isopropyl
Brand RESCULA
Mechanism Unknown
Route OPHTHALMIC
Formulation SOLUTION/DROPS
Mechanism of action
Unknown
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is unoprostone isopropyl?
unoprostone isopropyl (RESCULA) is a unknown. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for unoprostone isopropyl?
RESCULA is a marketed brand name for unoprostone isopropyl. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of unoprostone isopropyl?
unoprostone isopropyl has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.